Name: Recombinant Human I-TAC/CXCL11 (Human I-TAC/CXCL11)_C230416
Brand: Arcegen
SKU: C230416E
Price: 74.0 USD

Recombinant Human I-TAC/CXCL11 (Human I-TAC/CXCL11)_C230416

Product form

Size

SKU: C230416E

$74.00

Synonyms	Beta-R1, H174, IP-9, Small-inducible Cytokine B1
Accession	O14625
GeneID	6373
Source	E.coli-derived Human CXCL11,Phe22-Phe94
Molecular Weight	Approximately 8.3 kD
AA Sequence	FPMFKRGRCL CIGPGVKAVK VADIEKASIM YPSNNCDKIE VIITLKENKG QRCLNPKSKQ ARLIIKKVER KNF
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	> 97% by SDS-PAGE and HPLC analyses
Biological Activity	Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human IL-2 activated human T-lymphocytes is in a concentration range of 0.1-10 ng/mL.
Endotoxin	< 1 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from a 0.2 µm filtered concentrated solution in 20 mM PB, pH 7.4, 100 mM NaCl
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Synonyms	Beta-R1, H174, IP-9, Small-inducible Cytokine B1
Accession	O14625
GeneID	6373
Source	E.coli-derived Human CXCL11,Phe22-Phe94
Molecular Weight	Approximately 8.3 kD
AA Sequence	FPMFKRGRCL CIGPGVKAVK VADIEKASIM YPSNNCDKIE VIITLKENKG QRCLNPKSKQ ARLIIKKVER KNF
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	> 97% by SDS-PAGE and HPLC analyses
Biological Activity	Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human IL-2 activated human T-lymphocytes is in a concentration range of 0.1-10 ng/mL.
Endotoxin	< 1 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from a 0.2 µm filtered concentrated solution in 20 mM PB, pH 7.4, 100 mM NaCl
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.